Navigation Links
ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records
Date:8/12/2008

ProSanos Corporation announced today the release of Sfetyworks™, a web-based, semi-automated software system that can help scientists more quickly spot and measure the strength of associations between a drug and a medical condition found within large electronic healthcare databases. Sfetyworks™ resulted from a partnership between GlaxoSmithKline plc (GSK) and ProSanos. Several years in development, it is now available to all pharmacovigilance professionals.

HARRISBURG, Pa. (Business Wire EON) August 12, 2008 -- The new software system, pioneered by GSK and ProSanos, is an efficient way to perform active drug surveillance and complement traditional epidemiologic studies. Using Sfetyworks™, drug safety experts will have the unprecedented ability to ask the same questions of different databases. Data from traditional sources, like adverse event reports and epidemiological studies, can quickly and reliably be compared with information from observational sources like insurance claims and electronic medical records. In addition, pharmacovigilance professionals will be able to control for multiple confounding factors, helping them to quickly distinguish unusual conditions that may be associated with a drug from conditions that are disease-related or limited to specific cohorts of patients.

Commenting on the co-development collaboration with ProSanos, Edward Pattishall, MD, VP Safety at GSK stated, "GSK is committed to enhancing patient safety and anticipates this tool will be extremely helpful in evaluating the benefit/risk profile of our medicines using multiple data sources that can't currently be easily and quickly compared.

It is an improvement over other software solutions because it can rapidly and simultaneously interrogate multiple databases and contribute to the evidence of a potential safety issue. We have made an up-front investment in developing this tool and we hope that others will benefit as enhancing patient safety is a common goal for everyone involved in the manufacture, administration and regulation of medicines."

Jonathan Morris, M.D., President and CEO of ProSanos Corporation, said, "In a post-market environment, robust well-designed technologies like Sfetyworks™ can be an important part of the solution to the challenges of drug safety surveillance. ProSanos looks forward to deploying the system with other participants in the process, so that even larger numbers of patients might benefit."

About ProSanos Corporation

The mission of ProSanos Corporation (www.prosanos.com) is to advance patient safety and care by providing clients and partners with superior products and services for the integration, analysis and management of healthcare-related data. Founded in 2000 and known for its innovative approach to the analysis and mining of healthcare data, the company provides products and services that promote in-depth understanding of the treatment of specific diseases and conditions. ProSanos Corporation is headquartered in Harrisburg, PA.

Read the full story at http://www.prweb.com/releases/prosanos/corporation/prweb1203364.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records 
(Date:10/13/2017)... ... October 13, 2017 , ... The International ... promote standards of excellence for the field of eating disorders, announces the opening ... 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes ... of the facility as part of a disaster drill on October 3rd. , Apple ... Shelton City Emergency Manager, as well as the Connecticut Long Term Care Mutual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... 2017 , ... Planet Fitness, one of the largest and fastest growing franchisors ... a flagship location in Covington, LA at 401 N. U.S. Highway 190, in January ... Office Depot in the Holiday Square shopping center. Its location allows it to serve ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: